ASURE: Alzheimer Study Using oRal Edaravone

Status:
Not yet recruiting

Trial end date:
2024-06-01

Target enrollment:

Participant gender:

This is a multi-center, Phase IIa, randomized, double-blind, placebo-controlled study in patients with Alzheimer's Disease (AD).

Phase 2

Treeway B.V.

Edaravone